Track the 皓元医药 stock price and the full management transaction log of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 皓元医药 has logged 9 public disclosures. Market capitalisation: €17.1bn. The latest transaction was reported on 25 June 2026 (Sale). Among the most active insiders: 李硕梁. The full history is openly available.
9
Insider Decl.
n/a
Thresholds
€109,271
1 ops.
Buy Volume
€789,452
8 ops.
Sell Volume
5Σ signal
Buys €109,271€789,452 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,611 of 28,752 companies
39.7
score / 100
Value
28
Quality
51
FCF yld0.5%
Earn yld1.2%
EV/EBITDA46.0x
ROE7.5%
Gross mgn47%
Net mgn8.3%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
皓元医药 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative drugs.